High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses

High-dose (HD) influenza vaccine shows improved relative efficacy against influenza disease compared to standard-dose (SD) vaccine in individuals ≥ 65 years. This has been partially credited to superior serological responses, but a comprehensive understanding of cell-mediated immunity (CMI) of HD va...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Kim, Jin Hyang, Talbot, H. Keipp, Mishina, Margarita, Zhu, Yuwei, Chen, Jufu, Cao, Weiping, Reber, Adrian J., Griffin, Marie R., Shay, David K., Spencer, Sarah M., Sambhara, Suryaprakash
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996724/
https://ncbi.nlm.nih.gov/pubmed/27473306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.07.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados